Real-time enrollment status for this advanced breast cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:24 PM UTC
| NCT Number | NCT06638307 |
| Recruiting Status | Recruiting |
| Condition | Advanced Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 240 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Stemline Therapeutics, Inc. |
| Last Updated on CT.gov | August 7, 2026 (Aug 7, 2026) |
As of October 12, 2026: Clinical trial NCT06638307 is currently recruiting participants. This phase1 study for advanced breast cancer is actively seeking new participants at 37 locations across the United States. The study is sponsored by Stemline Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06638307 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06638307 was last updated Aug 7, 2026 (August 7, 2026). HelloStudys verifies this status automatically.